Loading…
Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?
Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential...
Saved in:
Published in: | Oral oncology 2017-05, Vol.68, p.9-19 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13 |
---|---|
cites | cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13 |
container_end_page | 19 |
container_issue | |
container_start_page | 9 |
container_title | Oral oncology |
container_volume | 68 |
creator | Shaikh, Mushfiq H Clarke, Daniel T.W Johnson, Newell W McMillan, Nigel A.J |
description | Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential delivery systems. • Targeting E6 & E7 could be an effective treatment strategy for HPV-positive HNSCC. |
doi_str_mv | 10.1016/j.oraloncology.2017.02.016 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891889486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837517300428</els_id><sourcerecordid>1891889486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhiNERT_gLyCLE5cEfyW2OYDQQgGpUg-Fs-U4k11vvfZie5H239dhC0KcOHmsed95Nc80zSuCO4LJ8GbbxWR8DDb6uD52FBPRYdrV1pPmgkihWtwr9rTWbJCtZKI_by5z3mKMe9LjZ805lZxJqtRFY1YmoDUEQDC54sIamTCh7DwEu_wK2E1YchxktPfmiAxK0QNyAZUNoJLAlB2EguKMNmCmX_4A9h5ZEyyk98-bs9n4DC8e36vm-_Wnb6sv7c3t56-rDzet5awv7UwEnntpubAElBio4HwkXNFJEKNGOnPBR0GlGsWoBpiY4b0a-QR1KyZGwq6a16e5-xR_HCAXvXPZgvcmQDxkTaQiUiouhyp9e5LaFHNOMOt9cjuTjppgvSDWW_03Yr0g1pjq2qrml485h3EH0x_rb6ZV8PEkgLrtTwdJZ-sqzgo4gS16iu7_ct79M8Z6F5w1_h6OkLfxkELlqYnO1aDvlmMvtyaCYcypZA90SqiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891889486</pqid></control><display><type>article</type><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><source>Elsevier</source><creator>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</creator><creatorcontrib>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</creatorcontrib><description>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential delivery systems. • Targeting E6 & E7 could be an effective treatment strategy for HPV-positive HNSCC.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2017.02.016</identifier><identifier>PMID: 28438299</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Carcinoma, Squamous Cell - therapy ; CRISPR/Cas ; Gene Editing ; Gene Silencing ; Head and Neck Neoplasms - therapy ; Head and neck squamous cell carcinoma ; Hematology, Oncology and Palliative Medicine ; Human papillomavirus ; Humans ; Nanoparticles and lipoplex ; Otolaryngology ; RNA Interference ; Short interfering RNA ; Squamous Cell Carcinoma of Head and Neck</subject><ispartof>Oral oncology, 2017-05, Vol.68, p.9-19</ispartof><rights>2017</rights><rights>Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</citedby><cites>FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28438299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaikh, Mushfiq H</creatorcontrib><creatorcontrib>Clarke, Daniel T.W</creatorcontrib><creatorcontrib>Johnson, Newell W</creatorcontrib><creatorcontrib>McMillan, Nigel A.J</creatorcontrib><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential delivery systems. • Targeting E6 & E7 could be an effective treatment strategy for HPV-positive HNSCC.</description><subject>Carcinoma, Squamous Cell - therapy</subject><subject>CRISPR/Cas</subject><subject>Gene Editing</subject><subject>Gene Silencing</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Head and neck squamous cell carcinoma</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Nanoparticles and lipoplex</subject><subject>Otolaryngology</subject><subject>RNA Interference</subject><subject>Short interfering RNA</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhiNERT_gLyCLE5cEfyW2OYDQQgGpUg-Fs-U4k11vvfZie5H239dhC0KcOHmsed95Nc80zSuCO4LJ8GbbxWR8DDb6uD52FBPRYdrV1pPmgkihWtwr9rTWbJCtZKI_by5z3mKMe9LjZ805lZxJqtRFY1YmoDUEQDC54sIamTCh7DwEu_wK2E1YchxktPfmiAxK0QNyAZUNoJLAlB2EguKMNmCmX_4A9h5ZEyyk98-bs9n4DC8e36vm-_Wnb6sv7c3t56-rDzet5awv7UwEnntpubAElBio4HwkXNFJEKNGOnPBR0GlGsWoBpiY4b0a-QR1KyZGwq6a16e5-xR_HCAXvXPZgvcmQDxkTaQiUiouhyp9e5LaFHNOMOt9cjuTjppgvSDWW_03Yr0g1pjq2qrml485h3EH0x_rb6ZV8PEkgLrtTwdJZ-sqzgo4gS16iu7_ct79M8Z6F5w1_h6OkLfxkELlqYnO1aDvlmMvtyaCYcypZA90SqiA</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Shaikh, Mushfiq H</creator><creator>Clarke, Daniel T.W</creator><creator>Johnson, Newell W</creator><creator>McMillan, Nigel A.J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</title><author>Shaikh, Mushfiq H ; Clarke, Daniel T.W ; Johnson, Newell W ; McMillan, Nigel A.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Carcinoma, Squamous Cell - therapy</topic><topic>CRISPR/Cas</topic><topic>Gene Editing</topic><topic>Gene Silencing</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Head and neck squamous cell carcinoma</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Nanoparticles and lipoplex</topic><topic>Otolaryngology</topic><topic>RNA Interference</topic><topic>Short interfering RNA</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaikh, Mushfiq H</creatorcontrib><creatorcontrib>Clarke, Daniel T.W</creatorcontrib><creatorcontrib>Johnson, Newell W</creatorcontrib><creatorcontrib>McMillan, Nigel A.J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaikh, Mushfiq H</au><au>Clarke, Daniel T.W</au><au>Johnson, Newell W</au><au>McMillan, Nigel A.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>68</volume><spage>9</spage><epage>19</epage><pages>9-19</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>Highlights • Gene silencing and editing technology is now routine in the laboratory. • Advanced bioinformatics of head and neck cancer is required. • Clinically useful delivery systems and target selection are critical barriers. • The PLAS, nano-patch & microneedle approaches could be potential delivery systems. • Targeting E6 & E7 could be an effective treatment strategy for HPV-positive HNSCC.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28438299</pmid><doi>10.1016/j.oraloncology.2017.02.016</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1368-8375 |
ispartof | Oral oncology, 2017-05, Vol.68, p.9-19 |
issn | 1368-8375 1879-0593 |
language | eng |
recordid | cdi_proquest_miscellaneous_1891889486 |
source | Elsevier |
subjects | Carcinoma, Squamous Cell - therapy CRISPR/Cas Gene Editing Gene Silencing Head and Neck Neoplasms - therapy Head and neck squamous cell carcinoma Hematology, Oncology and Palliative Medicine Human papillomavirus Humans Nanoparticles and lipoplex Otolaryngology RNA Interference Short interfering RNA Squamous Cell Carcinoma of Head and Neck |
title | Can gene editing and silencing technologies play a role in the treatment of head and neck cancer? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A47%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20gene%20editing%20and%20silencing%20technologies%20play%20a%20role%20in%20the%20treatment%20of%20head%20and%20neck%20cancer?&rft.jtitle=Oral%20oncology&rft.au=Shaikh,%20Mushfiq%20H&rft.date=2017-05-01&rft.volume=68&rft.spage=9&rft.epage=19&rft.pages=9-19&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2017.02.016&rft_dat=%3Cproquest_cross%3E1891889486%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-f170f58c47c1e9762744b1492d71a9b2f474b7289b7b96ed3a459b4de00037b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1891889486&rft_id=info:pmid/28438299&rfr_iscdi=true |